Reversible Myopathy Induced By Long-Term Pegasys Mono Treatment for a Chronic Hepatitis C Patient under HALT-C Trial

被引：0
|
作者：
Cai, Chunyu [1 ]
Gioaccotto, Josh [1 ]
Felice, Kevin
Grunnet, Margaret [1 ]
Whitaker, Charles
Wu, Qian [1 ]
机构：
[1] Univ Connecticut, Ctr Hlth, Storrs, CT 06269 USA
来源：
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | 2009年 / 68卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
111
引用
收藏
页码：580 / 580
页数：1
相关论文
共 50 条
  • [21] RELATIONSHIP OF IRON [FE] AND HFE GENETIC VARIATIONS TO PROGRESSION AND OUTCOMES OF ADVANCED CHRONIC HEPATITIS C IN THE HALT-C TRIAL
    Lambrecht, Richard W.
    Naishadham, Deepa
    Sterling, Richard K.
    Rogers, Thomas E.
    Morishima, Chihiro
    Stoddard, Anne M.
    Bonkovsky, Herbert L.
    HEPATOLOGY, 2009, 50 (04) : 1050A - 1050A
  • [22] Progression of Advanced Chronic Hepatitis C (CHC): Further Follow-up Results From the Halt-C Trial
    Dienstag, Jules L.
    Bonkovsky, Herbert L.
    Kim, Hae-Young
    Seeff, Leonard B.
    Di Bisceglie, Adrian M.
    Szabo, Gyongyi
    Wright, Elizabeth C.
    GASTROENTEROLOGY, 2010, 138 (05) : S780 - S781
  • [23] Retreatment and long-term therapy with peginterferon: the HALT-C, EPIC3 and COPILOT studies
    Rizzetto, M
    JOURNAL OF CHEMOTHERAPY, 2006, 18 : 16 - 20
  • [24] Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: Results from the HALT-C trial
    Fontana, Robert J.
    Sanyal, Arun J.
    Mehta, Savant
    Doherty, Michael C.
    Neuschwander-Tetri, Brent A.
    Everson, Gregory T.
    Kahn, Jeffrey A.
    Malet, Peter F.
    Sheikh, Muhammad Y.
    Chung, Raymond T.
    Ghany, Marc G.
    Gretch, David R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (05): : 983 - 992
  • [25] REDUCED HEPATIC INFLAMMATION IS RELATED TO HCV RNA SUPPRESSION AND CORRELATES WITH LESS FIBROSIS PROGRESSION AND FEWER CIRRHOSIS COMPLICATIONS IN THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C) TRIAL
    Morishima, Chihiro
    Shiffman, Mitchell L.
    Lindsay, Karen
    Szabo, Gyongyi
    Dienstag, Jules L.
    Wright, Elizabeth C.
    HEPATOLOGY, 2008, 48 (04) : 434A - 434A
  • [26] RATE OF PROGRESSION OF HEPATIC FIBROSIS IN PATIENT WITH CHRONIC HEPATITIS C (CHC) PREDICTS NON-HCC AND HCC OUTCOMES: RESULTS FROM THE HALT-C TRIAL
    Hoofs, John C.
    Shiffman, Mitchell L.
    Goodman, Zachary
    Kleiner, David E.
    Stoddard, Anne M.
    Dienstag, Jules L.
    HEPATOLOGY, 2010, 52 (04) : 412A - 412A
  • [27] Iron and HFE gene mutations in advanced chronic hepatitis C (CHC): Results from the lead-in phase of the HALT-C trial
    Bonkovsky, HL
    Di Bisceglie, AM
    Morishima, C
    Chung, RT
    Everson, GT
    Ghany, MG
    Hoofnagle, JH
    Lindsay, KL
    Hoefs, JC
    Lee, WM
    Lok, AS
    Shiffman, ML
    Wright, EC
    HEPATOLOGY, 2005, 42 (04) : 548A - 548A
  • [28] VARIANTS ASSOCIATED WITH VITAMIN D METABOLISM AND PROGRESSION TO HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS C: DBGAP DATA FROM HALT-C TRIAL
    De Azevedo, L. A.
    Matte, U. D. S.
    Silveira, T. R.
    Alvares-da-Silva, M. R.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S334 - S334
  • [29] Patient Mortality and Liver Transplantation During the Halt-C Trial: Relationship to Chronic Liver Disease and Interferon Therapy
    Di Bisceglie, Adrian M.
    Dienstag, Jules L.
    Shiffman, Mitchell L.
    Seeff, Leonard B.
    Bonkovsky, Herbert L.
    Morishima, Chihiro
    Wright, Elizabeth C.
    Snow, Kristin K.
    Stoddard, Anne
    GASTROENTEROLOGY, 2010, 138 (05) : S838 - S839
  • [30] HEPATIC IMPAIRMENT MEASURED BY QUANTITATIVE TESTS OF LIVER FUNCTION (QLFTS) PREDICTS CLINICAL OUTCOME IN PATIENTS WITH ADVANCED FIBROSIS: RESULTS FROM THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C) TRIAL
    Everson, Gregory T.
    Hoefs, John C.
    Shiffman, Mitchell L.
    Morgan, Timothy R.
    Sterling, Richard K.
    Curto, Teresa M.
    Wagner, David
    Wright, Elizabeth C.
    Everhart, James E.
    HEPATOLOGY, 2009, 50 (04) : 1057A - 1058A
12345